The panel can't satisfy Sharp: it is the way out for entering the medical field.

February 28, 2017 news, Sharp has opened the road to rejuvenation since it was acquired by Hon Hai, and in the panel business is to maximize its strengths. However, according to the current situation, the panel business seems to have failed to meet Sharp. It is understood that its next target is the medical market, and it intends to be a high-end technology product.

富士康真是点金手?夏普首次扭亏为盈

It is reported that Sharp has announced that it will form a business alliance with Fabrigene, a subsidiary of Hon Hai. Sharp will split some medical Boajian and medical businesses into four companies through business transfer, including one holding company and three operating companies. For the company, the holding company was established by the joint venture of Sharp and Fabrigene.

Fabrigene invested $25 million to acquire a nearly 51.2% stake in Sharp's Sharp Healthcare and Medical Company KY, with the remaining 48.8% held by Sharp. The three operating companies are Sharp Science, Sharp Healthcare (UK) and Lacamas Statement Science. The main purpose of the operating company is to be responsible for the new business, that is, the promotion of medical business, and the three new companies will be launched on March 1.

Organic Balsam Pear Powder

Organic Balsam Pear Powder,Bitter Melon Powder,Bitter Gourd Powder,Balsam Pear Powder

Hengshui Shanzhi Health Drink Co., Ltd , https://www.grasspowder-sz.com